Sudo Katsumi

Faculty of Medicine
Official title
C(|102*&I02!,%I10@OK*!I102(2}|I| I'-
Research fields
Pharmacology in pharmacy
Research keywords
Drug Discovery Research, Preclinical Pharmacology, Translational Science. Translational Research, Biomarker, Big Data, Precision Medicine
Career history
2018-07 -- (current)日本大学医学部客員教授
2018-01 -- (current)岡山大学大学院医歯薬学総合研究科非常勤講師
2017-04 -- 2020-03京都大学大学院医学研究科先端医療基盤共同研究講座特任教授(協働)
2017-04 -- 2020-03アステラス製薬株式会社京都大学アライアンスステーション担当部長
2015-04 -- (current)筑波大学大学院ライフイノベーション学位プログラム教授
2014-04 -- 2017-03アステラス製薬株式会社Translational Science Research LabsVice President
2010-10 -- 2014-03アステラス製薬株式会社研究推進部トランスレーショナルサイエンス担当次長
2006-11 -- 2010-09アステラス製薬株式会社薬理研究所主席研究員
2005-11 -- 2006-10Astellas Pharma Europe BVTranslational Science Section, Exploratory Development DivisionTranslational Scientist
2005-04 -- 2005-10アステラス製薬株式会社薬理研究所主席研究員
Licenses and qualifications
Academic societies
1984-04 -- (current)The Japanese Pharmacological Society
  • ラット頸動脈バルーン内皮障害モデルにおける新規アンジオテンシンAT1受容体拮抗薬Telmisartan(ミカルディス(R))の血管反応性改善作用の検討
    須藤 勝美
    薬理と臨床/13(2)/pp.127-136, 2003
  • Telmisartan(ミカルディス(R))のヒト血小板に対する作用
    須藤 勝美
    薬理と臨床/13(2)/pp.121-126, 2003
  • ヒト型アンジオテンシンII受容体に対するTelmisartan(ミカルディス(R))の結合特性
    須藤 勝美
    薬理と臨床/13(2)/pp.111-119, 2003
  • 創薬におけるトランスレーショナル研究の課題と展望
    須藤 勝美
    Folia Pharmacologica Japonica/148(6)/pp.296-301, 2016
  • The effect of intravenous recombinant human renin on blood pressure in pithed spontaneously hypertensive rats.
    Sudo Katsumi
    European Journal of Pharmacology/215(2-3)/pp.271-276, 1992
  • Effect of the optical isomers of YM-12617 on increased intra-urethral pressure induced by phenylephrine in anaesthetized dogs.
    Sudo Katsumi
    Journal of Autonomic Pharmacology/12(4)/pp.263-268, 1992
  • Characterization of [3H]YM617, R-(-)-5-[2-[[2[ethoxyring(n)-3H](o-ethoxyphenoxy)ethyl]amino]-propyl]-2-methoxybenzenesulfonamide HCl, a potent and selective alpha-1 adrenoceptor radioligand.
    Sudo Katsumi
    Journal of Pharmacology and Experimental Therapautics/263(1)/pp.201-206, 1992
  • Characterization of the adrenoceptor antagonistic and antihypertensive activity of oral amosulalol, a combined alpha- and beta-adrenoceptor antagonist, in hypertensive rats.
    Sudo Katsumi
    Journal of Cardiovascular Pharmacology/24(5)/pp.794-802, 1994
  • Effect of tamsulosin, a novel alpha 1-adrenoceptor antagonist, on urethral pressure profile in anaesthetized dogs.
    Sudo Katsumi
    journal of Autonomic Pharmacology/16(3)/pp.147-154, 1996
  • Effect of alpha 1-adrenoceptor antagonists on urinary bladder function in urethane-anesthetized rats.
    Sudo Katsumi
    General Pharmacology/28(4)/pp.521-524, 1997
  • Responsiveness of smooth muscle in the lower urinary tract of rabbits to various agonists.
    Sudo Katsumi
    General Pharmacology/28(4)/pp.629-631, 1997
  • Different effect of anticholinergic agents and potassium channel openers on urinary bladder response to pelvic nerve stimulation in anaesthetized dogs.
    Sudo Katsumi
    Journal of Autonomic Pharmacology/17(2)/pp.91-96, 1997
  • Effect of YM435, a novel dopamine DA1 receptor agonist, in a canine model of acute congestive heart failure.
    Sudo Katsumi
    General Pharmacology/30(5)/pp.733-737, 1998
  • Ethenesulfonamide derivatives, a novel class of orally active endothelin-A receptor antagonists.
    Sudo Katsumi
    Chemical and Pharmaceutical Bulletin/45(5)/pp.606-612, 2001
  • Ethenesulfonamide and ethanesulfonamide derivatives, a novel class of orally active endothelin-A receptor antagonists
    Sudo Katsumi
    Bioorg Med Chem/9(11)/pp.2955-2968, 2001
  • Synthesis and structure-activity relationships in a series of ethenesulfonamide derivatives, a novel class of endothelin receptor antagonists.
    Sudo Katsumi
    Chemical and Pharmaceutical Bulletin/49(12)/pp.1593-1603, 2001
  • Pharmacological characterization of YM598, an orally active and highly potent selective endothelin ET(A) receptor antagonist.
    Sudo Katsumi
    European Journal of Pharmacology/478(1)/pp.61-71, 2003
  • Effect of single oral administration of YM598, a novel selective endothelin ETA receptor antagonist, on blood pressure in normotensive and hypertensive rats.
    Sudo Katsumi
    Vascular Pharmacology/41(1)/pp.27-34, 2004
  • Effects of selective endothelin ET(A) receptor antagonists on endothelin-1-induced potentiation of cancer pain.
    Sudo Katsumi
    European Journal of Pharmacology/492(2-3)/pp.177-182, 2004
  • The orally active nonpeptide selective endothelin ETA receptor antagonist YM598 prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats.
    Sudo Katsumi
    European Journal of Pharmacology/496(1-3)/pp.129-139, 2004
  • Superiority of YM598 over atrasentan as a selective endothelin ETA receptor antagonist.
    Sudo Katsumi
    European Journal of Pharmacology/13(498)/pp.171-177, 2004
  • Intravenous administration of conivaptan hydrochloride improves cardiac hemodynamics in rats with myocardial infarction-induced congestive heart failure.
    Sudo Katsumi
    European Journal of Pharmacology/507(1-3)/pp.145-151, 2005
  • YM598, an Orally Active ETA Receptor Antagonist, Ameliorates the Progression of Cardiopulmonary Changes and Both-side Heart Failure in Rats with Cor Pulmonale and Myocardial Infarction.
    Sudo Katsumi
    Journal of Cardiovascular Pharmacology/44(S1)/pp.S354-S357, 2004
  • Pharmacological Characterization of YM598, a Selective Endothelin-A Receptor Antagonist.
    Sudo Katsumi
    Journal of Cardiovascular Pharmacology/44(S1)/pp.S390-S393, 2004
  • Inhibitory Effects of a Selective Endothelin-A Receptor Antagonist YM598 on Endothelin-1-induced Potentiation of Nociception in Formalin-induced and Prostate Cancer-induced Pain Models in Mice.
    Sudo Katsumi
    Journal of Cardiovascular Phamacology/44(S1)/pp.S479-S482, 2004
  • more...
  • 臨床研究段階における医薬品分析
    須藤 勝美
    創薬の分析化学:開発タイムラインにそった全過程/丸善出版/pp.177-187, 2011
Conference, etc.
  • 生体情報から創薬へ展開する薬剤疫学
    須藤 勝美
  • Precision Medicineにおけるトランスレーショナル研究の現状と展望
    須藤 勝美
  • 創薬とトランスレーショナルリサーチ
    須藤 勝美
    第3回東京理科大学総合研究院TRセンター シンポジウム/研究交流会/2016-01-23--2016-01-23
  • 製薬企業におけるトランスレーショナルメディシンの課題
    須藤 勝美
    日経バイオテク プロフェッショナルセミナー/2015-12-01--2015-12-01
  • ビッグデータ利活用で変わる医薬品開発
    須藤 勝美
    Hitachi SOCIAL INNOVATION FORUM 2015/2015-10-29--2015-10-30
  • 予測・予防・個別化・住民参加の保健医療に向けて
    須藤 勝美
    ベンチャー支援機構MINERVA 発足15周年シンポジウム/2015-03-26--2015-03-26
  • 日本製薬企業に於けるトランスレーショナルリサーチの現状と課題
    須藤 勝美
    第88回日本薬理学会年会 企業シンポジウム/2015-03-18--2015-03-20

(Last updated: 2022-08-01)